BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 9275209)

  • 1. Delayed loss of cholesterol from a localized lipoprotein depot in apolipoprotein A-I-deficient mice.
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Breslow JL; Stein Y
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9820-4. PubMed ID: 9275209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
    Atherosclerosis; 1999 Jun; 144(2):367-74. PubMed ID: 10407497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone impairs cholesterol egress from a localized lipoprotein depot in vivo.
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Stein Y
    Atherosclerosis; 1998 Apr; 137(2):303-10. PubMed ID: 9622273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol efflux in vivo from a depot of cationized LDL injected into a thigh muscle of small rodents.
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Halperin G; Okon E; Stein Y
    Atherosclerosis; 1997 Aug; 133(1):15-22. PubMed ID: 9258402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
    Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LXR activation and cholesterol efflux from a lipoprotein depot in vivo.
    Stein Y; Stein O; Dabach Y; Halperin G; Ben-Naim M
    Biochim Biophys Acta; 2004 Nov; 1686(1-2):24-9. PubMed ID: 15522819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plasma lipoprotein containing only apolipoprotein E and with gamma mobility on electrophoresis releases cholesterol from cells.
    Huang Y; von Eckardstein A; Wu S; Maeda N; Assmann G
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1834-8. PubMed ID: 8127890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of interactions of apolipoprotein A-II with apolipoproteins A-I or A-IV on [3H]cholesterol efflux and uptake in cell culture.
    Stein O; Dabach Y; Hollander G; Ben-Naim M; Oette K; Stein Y
    Biochim Biophys Acta; 1995 Jul; 1257(2):174-80. PubMed ID: 7619858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic fate of apolipoprotein A-I-containing lipoproteins internalized into HepG2 cells: resecreted lipoproteins as a potent inducer for cholesterol efflux.
    Sasahara T; Kobori S; Kasho M; Sato Y; Nishikawa T; Yano T; Takeda H; Shichiri M
    Atherosclerosis; 1994 Apr; 106(2):179-90. PubMed ID: 8060378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
    Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of HDL apolipoprotein E in cellular cholesterol efflux: studies in apo E knockout transgenic mice.
    Hayek T; Oiknine J; Brook JG; Aviram M
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1072-8. PubMed ID: 7802634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clearance of cationized LDL cholesterol from a muscle depot is not enhanced in human apolipoprotein A-IV transgenic mice.
    Stein Y; Stein O; Duverger N; Halperin G; Dabach Y; Hollander G; Ben-Naim M
    Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):179-84. PubMed ID: 10634815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining the atherogenicity of large and small lipoproteins containing apolipoprotein B100.
    Véniant MM; Sullivan MA; Kim SK; Ambroziak P; Chu A; Wilson MD; Hellerstein MK; Rudel LL; Walzem RL; Young SG
    J Clin Invest; 2000 Dec; 106(12):1501-10. PubMed ID: 11120757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous apolipoprotein E modulates cholesterol efflux and cholesteryl ester hydrolysis mediated by high-density lipoprotein-3 and lipid-free apolipoproteins in mouse peritoneal macrophages.
    Langer C; Huang Y; Cullen P; Wiesenhütter B; Mahley RW; Assmann G; von Eckardstein A
    J Mol Med (Berl); 2000; 78(4):217-27. PubMed ID: 10933584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis.
    Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P
    Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased esterification of cholesterol and transfer of cholesteryl ester to apo B-containing lipoproteins in Type 2 diabetes: relationship to serum lipoproteins A-I and A-II.
    Jones RJ; Owens D; Brennan C; Collins PB; Johnson AH; Tomkin GH
    Atherosclerosis; 1996 Jan; 119(2):151-7. PubMed ID: 8808492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E-deficient mice created by systemic administration of antisense oligodeoxynucleotides: a new model for lipoprotein metabolism studies.
    Morishita R; Gibbons GH; Kaneda Y; Zhang L; Ogihara T; Dzau VJ
    J Endocrinol; 2002 Nov; 175(2):475-85. PubMed ID: 12429045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apolipoprotein A-I complexed with phospholipid promotes hepatic lipoprotein and apolipoprotein secretion in the perfused hamster liver.
    Song W; Chen J; Redinger RN
    J Investig Med; 1998 Dec; 46(9):460-9. PubMed ID: 9861782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hepatic lipoprotein receptors in the dog. Rapid regulation of apolipoprotein B,E receptors, but not of apolipoprotein E receptors, by intestinal lipoproteins and bile acids.
    Angelin B; Raviola CA; Innerarity TL; Mahley RW
    J Clin Invest; 1983 Apr; 71(4):816-31. PubMed ID: 6300188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol efflux potential of sera from mice expressing human cholesteryl ester transfer protein and/or human apolipoprotein AI.
    Atger V; de la Llera Moya M; Bamberger M; Francone O; Cosgrove P; Tall A; Walsh A; Moatti N; Rothblat G
    J Clin Invest; 1995 Dec; 96(6):2613-22. PubMed ID: 8675626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.